— Know what they know.
Not Investment Advice
Also trades as: NDAT.CN (CNQ) · $vol 0M

NDATF OTC

nDatalyze Corp.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +633.9% 1Y: +633.9% 3Y: -46.7%
$0.08
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Healthcare Information Services · Tech Score Sell · Power 40 · $3.3M mcap · 29M float · 0.0005% daily turnover · Short 72% of daily vol

Income Trends

Revenue
$0 -100.0% ▼
Gross Profit
-$2K -219.6% ▼
Operating Income
-$218K +65.8% ▲
Net Income
-$212K +61.8% ▲
EPS (Diluted)
$-0.01 +61.7% ▲
EBITDA
-$217K +65.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
Revenue$425K$171K$96K$2K$0
YoY Growth-35.9%-59.7%-43.7%-98.2%-100.0%
Cost of Revenue$195K$126K$29K$161$2K
Gross Profit$230K$45K$67K$2K-$2K
Gross Margin54.1%26.2%69.9%90.6%—
R&D Expenses$832K$255K$146K$89K$56K
SG&A Expenses$550K$647K$87K$151K$112K
Operating Expenses$1M$1M$523K$640K$217K
Operating Income-$903K-$942K-$455K-$638K-$218K
Operating Margin-212.6%-549.9%-472.7%-37220.5%—
Interest Expense$5K$2K$2K$0$3K
Income Before Tax-$1M-$1M-$294K-$554K-$201K
Tax Expense$0$0-$139K$0$11K
Net Income-$1M-$1M-$156K-$554K-$212K
Net Margin-276.2%-719.6%-161.5%-32349.8%—
EPS (Diluted)$-0.03$-0.03$-0.00$-0.01$-0.01
EBITDA-$1M-$1M-$429K-$636K-$217K
Shares Outstanding37M39M39M42M41M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms